Rie Schultz Hansen

Rie has more than 15 years of pharmaceutical industry and management experience. She has built her career at Zealand Pharma across multiple functional areas where she served as VP, Head of Discovery and Innovation, Interim CSO and VP of Biology, Inflammation and GI diseases governing the preclinical portfolio until CTA/IND submission and developing and implementing the strategy for Research and CMC for all pre clinical projects She has been working extensively on peptides as a modality, also venturing into different therapeutic areas Dr Schultz Hansen obtained her Master in Biology and PhD at Faculty of Medicine, University of Copenhagen and she serves as Board member of Peptide Therapeutics Foundation.